Fundraising Fox

Opus Genetics

NASDAQ: IRD

Farmington Hills, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

DJ
Dr. Jean BennettFounder
DB
Dr. Benjamin YerxaExecutive
BH
Bernhard HoffmannExecutive
NJ
Nirav JhaveriExecutive
AJ
Ash JayagopalExecutive
AR
Amy RabournExecutive
MS
Mina SoochNamed on SEC filing
AR
Alan R. MeyerNamed on SEC filing

Board

SA
Sean AinsworthBoard director
DA
Dr. Adrienne GravesBoard director
RR
Richard RodgersBoard director
JM
James ManusoBoard director

Investors · 1

Oberland CapitalreportedNew York · $50M – $300M

Reported raises · per SEC filings

Form D private placements

$46.9M disclosed across 2 rounds · 2020–2024

▶$25.8MraisedNov 2024 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dr. Jean BennettDirector
  • Dr. Benjamin YerxaDirector, Executive Officer
  • Sean AinsworthDirector
  • Bernhard HoffmannExecutive Officer
  • Dr. Adrienne GravesDirector
  • Richard RodgersDirector
  • James ManusoDirector
  • Nirav JhaveriExecutive Officer
  • Ash JayagopalExecutive Officer
  • Cam GallagherDirector
  • Susan BentonDirector
  • Amy RabournExecutive Officer
  • Joseph SchachleExecutive Officer
  • Dr. George MagrathDirector, Executive Officer
Offering amount
$25.8M
Amount sold
$25.8M
First sale
Oct 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.1MraisedNov 2020 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James S. ManusoDirector
  • Mina SoochExecutive Officer, Director
  • Alan R. MeyerDirector
  • Sean AinsworthDirector
  • Amy Zaremba RabournExecutive Officer
  • Cam GallagherDirector
  • Susan K. BentonDirector
  • Richard J. RodgersDirector
  • Bernhard HoffmannExecutive Officer
Offering amount
$21.1M
Amount sold
$21.1M
Sales commissions
$1.6M
Placement agents
Canaccord Genuity LLC, Cantor Fitzgerald & Co.
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Opus Genetics (Nasdaq: IRD) posts Q2 2026 loss, extends cash runway into 2029stocktitan.net · Aug 2026Opus Genetics completes enrollment in LCA5 gene therapy trial By Investing.cominvesting.com · Aug 2026Opus Genetics Secures $155 Million Financing to Accelerate Gene Therapy Pipeline — Foundation Fighting Blindnessfightingblindness.org · Apr 2026Opus Genetics lands $155M financing, runway to 2029 | IRD Stock Newsstocktitan.net · Apr 2026

Frequently asked questions

Who founded Opus Genetics?
Opus Genetics was founded by Dr. Jean Bennett.
Who are Opus Genetics's investors?
Opus Genetics's investors include Oberland Capital.
How much funding has Opus Genetics raised?
Opus Genetics has disclosed $46.9M raised across 2 rounds.
Where is Opus Genetics headquartered?
Opus Genetics is headquartered in Farmington Hills, US.